Cleared Special

K230020 - BriefCase

K230020 is an FDA 510(k) clearance for BriefCase, manufactured by Aidoc Medical , Ltd.. The device is a Class 2 Radiology device with product code QFM cleared through the Special 510(k) pathway after a 29-day FDA review.

K230020 · Aidoc Medical , Ltd. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2023
Decision
29d
Days
Class 2
Risk

K230020 is an FDA 510(k) clearance for the BriefCase. Classified as Radiological Computer-assisted Prioritization Software For Lesions (product code QFM), Class II - Special Controls.

Submitted by Aidoc Medical , Ltd. (Tell-Aviv, IL). The FDA issued a Cleared decision on February 1, 2023 after a review of 29 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2080 - the FDA radiology and imaging software oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Aidoc Medical , Ltd. devices

FDA 510(k) Submission Details - K230020

510(k) Number K230020 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 03, 2023
Decision Date February 01, 2023
Days to Decision 29 days
Submission Type Special
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
78d faster than avg
Panel avg: 107d · This submission: 29d
Pathway characteristics
Modification to existing cleared device.

QFM Device Classification - Class 2, Special Controls

Product Code QFM Radiological Computer-assisted Prioritization Software For Lesions
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2080
Definition Radiological Computer-assisted Prioritization Software For Lesions Is An Image Processing Device Intended To Aid In Prioritization And Triage Of Time Sensitive Patient Detection And Diagnosis Based On The Analysis Of Medical Images Acquired From Radiological Signal Acquisition Systems. The Device Identifies Or Prioritizes Time Sensitive Imaging For Review By Prespecified Clinical Users Based On Software-based Image Analysis But Does Not Provide Information From The Image Analysis Other Than Triage And Notification.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Hogan Lovells US LLP
John J Smith

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - QFM Radiological Computer-assisted Prioritization Software For Lesions

All 39
Devices cleared under the same product code (QFM) and FDA review panel - the closest regulatory comparables to K230020.
Annalise Enterprise CXR Triage Trauma
K222179 · Annalise-Ai Pty , Ltd. · Mar 2023
Annalise Enterprise CXR Triage Trauma
K222268 · Annalise-Ai Pty , Ltd. · Mar 2023
Viz AAA
K223443 · Viz. Ai, Inc. · Mar 2023
QOCA image Smart CXR Image Processing System
K221868 · Quanta Computer, Inc. · Jan 2023
BriefCase
K222692 · Aidoc Medical , Ltd. · Dec 2022
EFAI ChestSuite XR Pneumothorax Assessment System
K221552 · Ever Fortune.Ai, Co., Ltd. · Nov 2022